Navigation Links
Cardiac Science Completes Deployment of AEDs With Los Angeles County Fire Department

BOTHELL, Wash., Jan. 18 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced that the Los Angeles County Fire Department equipped its first responder units with 425 Powerheart(R) G3 and G3 Pro(R) automated external defibrillators (AEDs).


"Like first responders everywhere, LA County Fire is a critical link in the survival chain, delivering life-saving trauma interventions immediately upon its arrival at an accident scene, or when responding to a sudden cardiac arrest," said Battalion Chief Ed Gandara, Emergency Medical Services Section. "A shock to the heart from an external defibrillator within a few minutes of a sudden cardiac arrest is absolutely critical. We want to equip our paramedics with the right equipment to increase the likelihood of resuscitating a victim." After thorough review, LA County Fire chose to outfit its units with Powerheart AEDs from Cardiac Science.

The Powerheart AED G3 and G3 Pro defibrillators are designed to be the most advanced and reliable defibrillation products on the market today. They meet and exceed tough clinical and environmental standards for professional fire and emergency medical services. Features on the G3 Pro include the industry's first ECG color display in an AED, manual override, three-lead monitoring and multiple rescue capability. These products also provide the ability to download rescue data to LA County Fire's data management system directly from the device, simplifying medical review and reporting of cardiac events.

"LA County required data connectivity from their AEDs," said Tony Titus, vice president of marketing. "Since our Quinton(R) and Burdick(R) cardiac monitoring products connect to many Health Information and Electronic Medical Record systems using our HeartCentrix(R) technology, we extended the application to our Powerheart AEDs to meet their specific requirements."

About Los Angeles County Fire Department

LA County Fire provides fire and EMS services to more than four million residents over 2,300 square miles in Los Angeles County, including 58 cities and towns. LA County Fire professionals include more than 2800 safety personnel, in addition to more than 700 lifeguards and numerous other support personnel. In 2006, LA County Fire first responders treated nearly 200,000 victims.

About the Powerheart AED by Cardiac Science

Having won more than 80 Powerheart patents, Cardiac Science engineers build AEDs with some of the most technologically advanced, easiest-to-use features available in AEDs today. Hospitals, police and fire departments use Powerheart AEDs to meet or exceed their demanding clinical needs. Major corporations, public agencies, airlines and airports, arenas, schools, hotels, casinos and consumers prefer Powerheart for its intuitive ease of use.

About Cardiac Science Corporation

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), Powerheart(R), Quinton(R), and HeartCentrix(R) brands, is headquartered in Bothell, Washington. The company, with customers in more than 100 countries worldwide, has operations in the United States (California and Wisconsin), Europe, and Asia. For information, call 425-402-2000 or visit

Forward-Looking Statements

This press release contains forward-looking statements including, but not limited to, those which infer that Cardiac Science Corporation's future revenue and profits may grow as a result of sales of defibrillation products. These statements and their underlying assumptions involve a number of risks and uncertainties and are not guarantees of future performance. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "intend," anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward looking. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2006. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

Cardiac Science Corporation Contact:

Mike Matysik

Senior Vice President and CFO


Investor Contact:

EVC Group, Inc.

Douglas Sherk/Jenifer Kirtland


Media Contact:

EVC Group, Inc.

Steve DiMattia


SOURCE Cardiac Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association
3. Family History Has Strong Effect on Cardiac Risk
4. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
5. Cardiac Science to Present at the UBS Global Life Sciences Conference
6. Cardiac Science Applauds Mass AED Training of Pittsburgh Educators
7. Guidelines help patients reduce risk of cardiac event before surgery
8. Cardiac Science Named to Deloittes Technology Fast 50 for Washington State
9. Cleveland Clinic and The Larry King Cardiac Foundation Partner to Provide Heart Surgery to Those in Need
10. Cardiac Science Releases New Cardiac Rehabilitation System
11. Cardiac Artery Trouble Boosts Family Heart Risk
Post Your Comments:
(Date:12/1/2015)... Illinois (PRWEB) , ... December 01, 2015 , ... ... and share medical images have been lifted as IMAGE Information Systems launches MED-TAB™ ... Society of North America Annual Meeting from November 29 to December 4, 2015. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken at ... accurate interpretation by the radiologist. The marking utensils are so small, however, they ... found a way to alleviate this problem. , He developed the patent-pending MARK ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... Health Center of Excellence (BHCOE) today announced that the organization has awarded Education ... San Francisco, with a Distinguished Award. The award celebrates exceptional special needs providers ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... XTC ... selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s largest ... CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015   Nottingham Spirk , ... announced the publication of a free whitepaper ... Medical Market". The whitepaper gives medical product companies, ... penetrating this lucrative segment. Nottingham Spirk ... to manage their own health, save money (i.e., ...
(Date:12/1/2015)... BOULDER, Colo. , Dec. 1, 2015 ... ARRY ) today announced that its Chief ... present at the Oppenheimer Annual Healthcare Conference ... to participate in the conference through a ... , --> ...
(Date:12/1/2015)... BANGALORE, India and ... (NASDAQ, TASE: MYL) today announced that it expects to ... for developing country markets funded by international donors, TLE400 ... + Efavirenz 400 mg) for $99 per patient, per ... (CHAI) to develop TLE400. The significantly reduced price could ...
Breaking Medicine Technology: